4
Changes in Ownership
Summit Therapeutics Inc. Filed Acc 0001871604-21-000004
Options or other derivatives
- VP Corporate Controller acquired 15,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Maranian Jeffrey R · VP Corporate Controller
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2021-12-15 | Grant or award : show line 1 in the form Stock Option (right to buy) | +15,000 | 15,000 | D |
Loading xslF345X03/wf-form4_163977535437475.xml…